Cargando…
Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer
BACKGROUND: Despite the near universal occurrence of activating codon 12 KRAS somatic variants in pancreatic cancer, there is considerable heterogeneity in the molecular make-up, MAPK/ERK pathway activation states, and clinical outcome in this disease. We analyzed the expression levels of CNKSR1, a...
Autores principales: | Quadri, Humair S., Aiken, Taylor J., Allgaeuer, Michael, Moravec, Radim, Altekruse, Sean, Hussain, S. Perwez, Miettinen, Markku M., Hewitt, Stephen M., Rudloff, Udo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522593/ https://www.ncbi.nlm.nih.gov/pubmed/28732488 http://dx.doi.org/10.1186/s12885-017-3481-4 |
Ejemplares similares
-
Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling
por: Li, Dandan, et al.
Publicado: (2023) -
CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP
por: Nishiyama, Kanako, et al.
Publicado: (2021) -
Functions of CNKSR2 and Its Association with Neurodevelopmental Disorders
por: Ito, Hidenori, et al.
Publicado: (2022) -
Case report: Phenotype expansion and analysis of TRIO and CNKSR2 variations
por: Liu, Yuefang, et al.
Publicado: (2022) -
Coordinating ERK signaling via the molecular scaffold Kinase Suppressor of Ras
por: Frodyma, Danielle, et al.
Publicado: (2017)